<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>Molecular Cytogenetics - Latest articles</title>
		<link>http://www.molecularcytogenetics.org</link>
		<description>The latest articles from Molecular Cytogenetics (ISSN 1755-8166) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/1/1/9"/>			    
            
				    <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/1/1/8"/>			    
            
				    <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/1/1/7"/>			    
            
				    <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/1/1/6"/>			    
            
				    <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/1/1/5"/>			    
            
				    <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/1/1/4"/>			    
            
				    <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/1/1/3"/>			    
            
				    <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/1/1/2"/>			    
            
				    <rdf:li rdf:resource="http://www.molecularcytogenetics.org/content/1/1/1"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.molecularcytogenetics.org/content/1/1/9">
            
            <title>Position of chromosomes 18, 19, 21 and 22 in 3D-preserved interphase nuclei of human and gorilla and white hand gibbon </title>
			<description>Background:
Even though comparative nuclear architecture studies in hominoids are sparse, nuclear chromosome architecture was shown to be conserved during hominoid evolution. Thus, it is suspected that yet unknown biological mechanisms must underlie this observation. 
Results:
Here for the first time a combination of multicolor banding (MCB) and three-dimensional analysis of interphase cells was used to characterize the position and orientation of human chromosomes #18, #19, #21 and #22 and their homologues in primate B-lymphocytic cells. In general, our data is in concordance with previous studies. The position of the four studied human chromosomes and their homologues were conserved during primate evolution. However, comparison of interphase architecture in human B-lymphocytic cells and sperm revealed differences of localization of acrocentric chromosomes. The latter might be related to the fact that the nucleolus organizing region is not active in sperm.
Conclusions:
Studies in different tissue types may characterize more - potentially biologically relevant differences in nuclear architecture. </description>
			<link>http://www.molecularcytogenetics.org/content/1/1/9</link>
			
			 	<dc:creator>Marina Manvelyan, Friederike Hunstig, Kristin Mrasek, Samarth Bhatt, Franck Pellestor, Anja Weise and Thomas Liehr</dc:creator>
			
			<dc:source>Molecular Cytogenetics 2008, 1:9</dc:source>
			<dc:date>2008-04-29</dc:date>
			<dc:identifier>doi:10.1186/1755-8166-1-9</dc:identifier>
			
			
							
					<prism:publicationName>Molecular Cytogenetics</prism:publicationName>
					
			
							
					<prism:issn>1755-8166</prism:issn>
					
			
							
					<prism:volume>1</prism:volume>
					
			
							
					<prism:startingPage>9</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.molecularcytogenetics.org/content/1/1/8">
            
            <title>Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication</title>
			<description>Background:
Interstitial deletions of 3q29 have been recently described as a microdeletion syndrome mediated by nonallelic homologous recombination between low-copy repeats resulting in an ~1.6 Mb common-sized deletion. Given the molecular mechanism causing the deletion, the reciprocal duplication is anticipated to occur with equal frequency, although only one family with this duplication has been reported. 
Results:
In this study we describe 14 individuals with microdeletions of 3q29, including one family with a mildly affected mother and two affected children, identified among 14,698 individuals with idiopathic mental retardation who were analyzed by array CGH. Eleven individuals had typical 1.6-Mb deletions. Three individuals had deletions that flank, span, or partially overlap the commonly deleted region. Although the clinical presentations of individuals with typical-sized deletions varied, several features were present in multiple individuals, including mental retardation and microcephaly. We also identified 19 individuals with duplications of 3q29, five of which appear to be the reciprocal duplication product of the 3q29 microdeletion and 14 of which flank, span, or partially overlap the common deletion region. The clinical features of individuals with microduplications of 3q29 also varied with few common features. De novo and inherited abnormalities were found in both the microdeletion and microduplication cohorts illustrating the need for parental samples to fully characterize these abnormalities.
Conclusions:
Our report demonstrates that array CGH is especially suited to identify chromosome abnormalities with unclear or variable presentations.</description>
			<link>http://www.molecularcytogenetics.org/content/1/1/8</link>
			
			 	<dc:creator>Blake C Ballif, Aaron Theisen, Justine Coppinger, Gordon C Gowans, Joseph H Hersh, Suneeta Madan-Khetarpal, Karen R Schmidt, Raymond Tervo, Luis F Escobar, Christopher A Friedrich, Marie McDonald, Lindsey Campbell, Jeffrey E Ming, Elaine H Zackai, Bassem A Bejjani and Lisa G Shaffer</dc:creator>
			
			<dc:source>Molecular Cytogenetics 2008, 1:8</dc:source>
			<dc:date>2008-04-28</dc:date>
			<dc:identifier>doi:10.1186/1755-8166-1-8</dc:identifier>
			
			
							
					<prism:publicationName>Molecular Cytogenetics</prism:publicationName>
					
			
							
					<prism:issn>1755-8166</prism:issn>
					
			
							
					<prism:volume>1</prism:volume>
					
			
							
					<prism:startingPage>8</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-28</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.molecularcytogenetics.org/content/1/1/7">
            
            <title>Unexpected structural complexity of supernumerary marker chromosomes characterized by microarray comparative genomic hybridization</title>
			<description>Background:
Supernumerary marker chromosomes (SMCs) are structurally abnormal extra chromosomes that cannot be unambiguously identified by conventional banding techniques. In the past, SMCs have been characterized using a variety of different molecular cytogenetic techniques. Although these techniques can sometimes identify the chromosome of origin of SMCs, they are cumbersome to perform and are not available in many clinical cytogenetic laboratories. Furthermore, they cannot precisely determine the region or breakpoints of the chromosome(s) involved. In this study, we describe four patients who possess one or more SMCs (a total of eight SMCs in all four patients) that were characterized by microarray comparative genomic hybridization (array CGH).
Results:
In at least one SMC from all four patients, array CGH uncovered unexpected complexity, in the form of complex rearrangements, that could have gone undetected using other molecular cytogenetic techniques. Although array CGH accurately defined the chromosome content of all but two minute SMCs, fluorescence in situ hybridization was necessary to determine the structure of the markers.
Conclusion:
The increasing use of array CGH in clinical cytogenetic laboratories will provide an efficient method for more comprehensive characterization of SMCs. Improved SMC characterization, facilitated by array CGH, will allow for more accurate SMC/phenotype correlation.</description>
			<link>http://www.molecularcytogenetics.org/content/1/1/7</link>
			
			 	<dc:creator>Karen D Tsuchiya, Kent E Opheim, Mark C Hannibal, Anne V Hing, Ian A Glass, Michael L Raff, Thomas Norwood and Beth A Torchia</dc:creator>
			
			<dc:source>Molecular Cytogenetics 2008, 1:7</dc:source>
			<dc:date>2008-04-21</dc:date>
			<dc:identifier>doi:10.1186/1755-8166-1-7</dc:identifier>
			
			
							
					<prism:publicationName>Molecular Cytogenetics</prism:publicationName>
					
			
							
					<prism:issn>1755-8166</prism:issn>
					
			
							
					<prism:volume>1</prism:volume>
					
			
							
					<prism:startingPage>7</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-21</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.molecularcytogenetics.org/content/1/1/6">
            
            <title>Complex rearranged small supernumerary marker chromosomes (sSMC), three new cases; evidence for an underestimated entity?</title>
			<description>Background:
Small supernumerary marker chromosomes (sSMC) are present ~2.6 &#215; 106 human worldwide. sSMC are a heterogeneous group of derivative chromosomes concerning their clinical consequences as well as their chromosomal origin and shape. Besides the sSMC present in Emanuel syndrome, i.e. der(22)t(11;22)(q23;q11), only few so-called complex sSMC are reported.
Results:
Here we report three new cases of unique complex sSMC. One was a de novo case with a dic(13 or 21;22) and two were maternally derived: a der(18)t(8;18) and a der(13 or 21)t(13 or 21;18). Thus, in summary, now 22 cases of unique complex sSMC are available in the literature. However, this special kind of sSMC might be under-diagnosed among sSMC-carriers.
Conclusion:
More comprehensive characterization of sSMC and approaches like reverse fluorescence in situ hybridization (FISH) or array based comparative genomic hybridization (array-CGH) might identify them to be more frequent than only ~0.9% among all sSMC.</description>
			<link>http://www.molecularcytogenetics.org/content/1/1/6</link>
			
			 	<dc:creator>Vladimir Trifonov, Simon Fluri, Franz Binkert, Adayapalam Nandini, Jasen Anderson, Laura Rodriguez, Madeleine Gross, Nadezda Kosyakova, Hasmik Mkrtchyan, Elisabeth Ewers, Daniela Reich, Anja Weise and Thomas Liehr</dc:creator>
			
			<dc:source>Molecular Cytogenetics 2008, 1:6</dc:source>
			<dc:date>2008-04-15</dc:date>
			<dc:identifier>doi:10.1186/1755-8166-1-6</dc:identifier>
			
			
							
					<prism:publicationName>Molecular Cytogenetics</prism:publicationName>
					
			
							
					<prism:issn>1755-8166</prism:issn>
					
			
							
					<prism:volume>1</prism:volume>
					
			
							
					<prism:startingPage>6</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-15</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.molecularcytogenetics.org/content/1/1/5">
            
            <title>An improved Diagnostic PCR Assay for identification of Cryptic Heterozygosity for CGG Triplet Repeat Alleles in the Fragile X Gene (FMR1)</title>
			<description>Background:
Fragile X syndrome (OMIM #300624) is the most common, recognised, heritable cause of mental retardation. Widespread testing is warranted by the relatively high frequency of the disorder, the benefits of early detection and the identification of related carriers whose offspring are at a 1 in 2 risk of inheriting the expanded pathogenic mutation. However, cost-effective screening of mentally retarded individuals has been impeded by the lack of a single, simple laboratory test. Currently, Fragile X syndrome can be excluded in males and a majority of females using a simple high-throughput PCR test. Due to the limited sensitivity of the PCR test, we find in our diagnostic service that approximately 40% of females appear homozygous and a labour intensive and expensive Southern blot test is required to distinguish these from females carrying one normal allele and an expanded allele.
Results:
We describe an improved PCR test which displays a high level of precision allowing alleles differing by a single triplet to be resolved. Using the new assay, we detected 46/83 (53%) cryptic heterozygotes previously labelled as homozygotes. The assay also extended the range of repeats amplifiable, up to 170 CGG repeats in males and 130 CGG repeats in females. Combined with the high precision, the assay also improves discrimination of normal (CGG repeats &lt; 45) from grey zone (45 &lt; CGG repeats &lt; 54) alleles and grey zone alleles from small premutations (55 &lt; CGG repeats &lt; 100).
Conclusion:
Use of this PCR test provides significantly improved precision and amplification of longer alleles. The number of follow-up Southern blot tests required is reduced (up to 50%) with consequent improvement in turnaround time and cost.</description>
			<link>http://www.molecularcytogenetics.org/content/1/1/5</link>
			
			 	<dc:creator>Mahmoud S Khaniani, Paul Kalitsis, Trent Burgess and Howard R Slater</dc:creator>
			
			<dc:source>Molecular Cytogenetics 2008, 1:5</dc:source>
			<dc:date>2008-04-08</dc:date>
			<dc:identifier>doi:10.1186/1755-8166-1-5</dc:identifier>
			
			
							
					<prism:publicationName>Molecular Cytogenetics</prism:publicationName>
					
			
							
					<prism:issn>1755-8166</prism:issn>
					
			
							
					<prism:volume>1</prism:volume>
					
			
							
					<prism:startingPage>5</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-08</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.molecularcytogenetics.org/content/1/1/4">
            
            <title>A new small supernumerary marker chromosome, generating mosaic pure trisomy 16q11.1&#8211;q12.1 in a healthy man</title>
			<description>Here we report on a healthy and fertile 30 years old man, who was carrier of a small supernumerary marker chromosome (sSMC). The application of molecular techniques such as fluorescence in situ hybridisation (FISH), microdissection and reverse painting, helped to characterize the sSMC which resulted to be derived from chromosome 16. In fact, the presence of euchromatin material from the long arm (16q) in the sSMC was demonstrated, and the karyotype can be written as mos 47, XY,+min(16)(:p11.1->q12.1:)[20]/46, XY [10].</description>
			<link>http://www.molecularcytogenetics.org/content/1/1/4</link>
			
			 	<dc:creator>Laura Rodr&#237;guez, Tomas Liehr, Mar&#237;a Luisa Mart&#237;nez-Fern&#225;ndez, Ana Lara, Antonio Torres and Mar&#237;a Luisa Mart&#237;nez-Fr&#237;as</dc:creator>
			
			<dc:source>Molecular Cytogenetics 2008, 1:4</dc:source>
			<dc:date>2008-04-02</dc:date>
			<dc:identifier>doi:10.1186/1755-8166-1-4</dc:identifier>
			
			
							
					<prism:publicationName>Molecular Cytogenetics</prism:publicationName>
					
			
							
					<prism:issn>1755-8166</prism:issn>
					
			
							
					<prism:volume>1</prism:volume>
					
			
							
					<prism:startingPage>4</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-02</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.molecularcytogenetics.org/content/1/1/3">
            
            <title>Direct fluorescent labelling of clones by DOP PCR</title>
			<description>Background:
Array Comparative Genomic Hybridisation (array CGH) is a powerful technique for the analysis of constitutional chromosomal anomalies. Chromosomal duplications or deletions detected by array CGH need subsequently to be validated by other methods. One method of validation is Fluorescence in situ Hybridisation (FISH). Traditionally, fluorophores or hapten labelling is performed by nick translation or random prime labelling of purified Bacterial Artificial Chromosome (BAC) products. However, since the array targets have been generated from Degenerate Oligonucleotide Primed (DOP) amplified BAC clones, we aimed to use these DOP amplified BAC clones as the basis of an automated FISH labelling protocol. Unfortunately, labelling of DOP amplified BAC clones by traditional labelling methods resulted in high levels of background.
Results:
We designed an improved labelling method, by means of degenerate oligonucleotides that resulted in optimal FISH probes with low background.
Conclusion:
We generated an improved labelling method for FISH which enables the rapid generation of FISH probes without the need for isolating BAC DNA. We labelled about 900 clones with this method with a success rate of 97%.</description>
			<link>http://www.molecularcytogenetics.org/content/1/1/3</link>
			
			 	<dc:creator>Liesbeth Backx, Reinhilde Thoelen, Hilde Van Esch and Joris R Vermeesch</dc:creator>
			
			<dc:source>Molecular Cytogenetics 2008, 1:3</dc:source>
			<dc:date>2008-03-26</dc:date>
			<dc:identifier>doi:10.1186/1755-8166-1-3</dc:identifier>
			
			
							
					<prism:publicationName>Molecular Cytogenetics</prism:publicationName>
					
			
							
					<prism:issn>1755-8166</prism:issn>
					
			
							
					<prism:volume>1</prism:volume>
					
			
							
					<prism:startingPage>3</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-26</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.molecularcytogenetics.org/content/1/1/2">
            
            <title>Submicroscopic chromosome imbalance in patients with developmental delay and/or dysmorphism referred specifically for Fragile X testing and karyotype analysis</title>
			<description>Background:
Microdeletion syndromes are generally identified because they usually give rise to specific phenotypic features; many of these deletions are mediated by duplicons or LCRs. The phenotypes associated with subtelomeric deletions are also becoming recognised. However, reciprocal duplication events at these loci are less easily recognised and identified, as they may give rise to milder phenotypic features, and the individuals carrying them may not therefore be referred for appropriate testing. 403 patients with developmental delay and/or dysmorphism, referred to our Genetics Centre for karyotyping and Fragile X expansion testing, were assessed for chromosome imbalance by Multiplex Ligation-dependent Probe Amplification (MLPA). Two MLPA kits were used, one containing probes for the subtelomere regions, and one containing probes for common microdeletion loci. 321 patients were tested with both kits, 75 with the subtelomere kit alone, and 7 with the microdeletion kit alone.
Results:
32 patients had abnormal results; the overall abnormality detection rate was 2.5% for karyotype analysis and 7.2% for MLPA testing; 5.5% of subtelomere tests and 2.1% of microdeletion tests gave abnormal results. Of the abnormal MLPA results, 5 were in cases with cytogenetically visible abnormalities; of the remaining, submicroscopic, changes, 3 results were established as de novo and 8 were inherited; parental samples were not available for the remaining cases. None of the patients was found to have a Fragile X expansion.
Conclusion:
Karyotype analysis in combination with MLPA assays for subtelomeres and microdeletion loci may be recommended for this patient group.</description>
			<link>http://www.molecularcytogenetics.org/content/1/1/2</link>
			
			 	<dc:creator>Joo Wook Ahn, Kathy Mann, Zoe Docherty and Caroline Mackie Ogilvie</dc:creator>
			
			<dc:source>Molecular Cytogenetics 2008, 1:2</dc:source>
			<dc:date>2008-03-26</dc:date>
			<dc:identifier>doi:10.1186/1755-8166-1-2</dc:identifier>
			
			
							
					<prism:publicationName>Molecular Cytogenetics</prism:publicationName>
					
			
							
					<prism:issn>1755-8166</prism:issn>
					
			
							
					<prism:volume>1</prism:volume>
					
			
							
					<prism:startingPage>2</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-26</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.molecularcytogenetics.org/content/1/1/1">
            
            <title>A new open access journal for a rapidly evolving biomedical field: introducing Molecular Cytogenetics</title>
			<description>Editorial - Introducing a new journal: Molecular Cytogenetics. An open access source for research concerning molecular cytogenetic techniques.</description>
			<link>http://www.molecularcytogenetics.org/content/1/1/1</link>
			
			 	<dc:creator>Yuri B Yurov, Thomas Liehr, Lisa G Shaffer, Ivan Y Iourov and Svetlana G Vorsanova</dc:creator>
			
			<dc:source>Molecular Cytogenetics 2008, 1:1</dc:source>
			<dc:date>2008-03-26</dc:date>
			<dc:identifier>doi:10.1186/1755-8166-1-1</dc:identifier>
			
			
							
					<prism:publicationName>Molecular Cytogenetics</prism:publicationName>
					
			
							
					<prism:issn>1755-8166</prism:issn>
					
			
							
					<prism:volume>1</prism:volume>
					
			
							
					<prism:startingPage>1</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-26</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
